ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve Replacement
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The primary aim is to determine the rate of major bleeding and blood clots when using
enoxaparin as a bridge to oral blood thinning medication in patients who have undergone
mechanical valve replacement.